SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Rapport Therapeutics Offers Convertible Senior Notes Due 2032

Rapport Therapeutics disclosed an offering of convertible senior notes due 2032; the offering size was not disclosed.

RAPP

Related stories